M&A Archives - Page 87 of 448

2 minute read

AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies

December 26, 7:46 AM

AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Gracell Biotechnologies Inc (NASDAQ: GRCL), further strengthening AstraZeneca's cell therapy portfolio.

AZN

1 minute read

Why Is 3D Printing Solutions Provider Stratasys Stock Soaring Today?

By Lekha Gupta

December 26, 7:35 AM

Stratasys Ltd (NASDAQ: SSYS) shares are trading higher after it disclosed receiving a preliminary acquisition proposal from

NNDM

1 minute read

M&A
News

AstraZeneca To Acquire Gracell Biotechnologies, Furthering Cell Therapy Ambition Across Oncology And Autoimmune Diseases For ~$1B

By Benzinga Newsdesk

December 26, 3:09 AM

Under the terms of the definitive agreement, AstraZeneca will acquire all of Gracell's fully diluted share capital (including shares represented by ADSs) through a merger for a price of $2.00 per ordinary

AZN

2 minute read

Billionaire Jim Ratcliffe Secures Minority Stake In Manchester United, Boosting Club’s Valuation To $6.3B

By Benzinga Neuro

December 24, 2:05 PM

British billionaire Jim Ratcliffe has bought a minority stake in Manchester United in a deal that values the football club at $6.3 billion.

MANU

2 minute read

Tech Giants In Talks: Synopsys Reportedly Aims For Blockbuster Acquisition Of Ansys In 2024

By Nabaparna Bhattacharya

December 23, 3:36 PM

Synopsys, Inc. (NASDAQ: SNPS) is reportedly in discussions about acquiring ANSYS, Inc. (NASDAQ: ANSS), a move that could result in the creation of a significant design-software entity and represent&n

AMD

4 minute read

Blaize, A Global Provider Of AI Solutions For Edge Computing, To Go Public Through A Business Combination With BurTech Acquisition Corp.

By Benzinga Newsdesk

December 22, 4:18 PM

Blaize is a provider of full-stack artificial intelligence ("AI") solutions for automotive and edge computing in multiple large and rapidly growing markets.

BRKH

1 minute read

With Karuna Therapeutics $14B Deal, Bristol Myers Is Serious For Re-Establishing Its Neurology Portfolio: Analyst

By Vandana Singh

December 22, 1:07 PM

Earlier Friday, Bristol Myers Squibb & Co (NYSE: BMY) agreed to acquire Karuna Therapeutics Inc (NASDAQ: KRTX) for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 bill

BMY

1 minute read

Insurance Company Fanhua Streamlines Its Ownership Structure In Puyi: Details

By Lekha Gupta

December 22, 12:27 PM

Puyi Inc (NASDAQ: PUYI) disclosed signing an agreement with Fanhua Inc (NASDAQ: FANH) to

FANH

1 minute read

Health Care Company Bristol-Myers Squibb Announces Merger With Karuna Therapeutics

By Benzinga Insights

December 22, 11:10 AM

Bristol-Myers Squibb (NYSE:BMY) has announced a merger with Karuna Therapeutics (NASDAQ:KRTX) that is expected to be completed 2024-H1.…

BMY

1 minute read

Lionsgate Forms $4.6B Studio Giant with Screaming Eagle SPAC Merger

By Anusuya Lahiri

December 22, 10:38 AM

Lionsgate announced that it would merge its Studio Business, which includes its Television Studio, Motion Picture Group segments, and an extensive film and television library, with special purpose acquisition company (SPAC) Screaming Eagle Acquisition Corp (NASDAQ: SCRM) to f

SCRM